Literature DB >> 27048834

Faecalibacterium prausnitzii phylotypes in type two diabetic, obese, and lean control subjects.

B Hippe1, M Remely1, E Aumueller1, A Pointner1, U Magnet1, A G Haslberger1.   

Abstract

Faecalibacterium prausnitzii is one of the main butyrate producers in the healthy human gut. Information on its genetic diversity is lacking, although two genetic phylotypes have been differentiated. In the present study, F. prausnitzii phylotypes were examined in faeces of obese and type two diabetes with similar eating behaviour compared to a lean control group. The purpose of the study was to analyse if an excessive butyrate production induced by different F. prausnitzii phylotypes discriminates between obese developing type two diabetes or not. The faecal samples were analysed for the total abundance of F. prausnitzii 16S rRNA copies, fragment lengths polymorphism, high resolution melt curve analysis (HRM) and the butyryl-CoA:acetate CoA-transferase gene copies and melt curve variances. The diabetic group was found to differ significantly from the lean control group in the results of qPCR, butyryl-CoA:acetyate CoA-transferase gene melt curve, and HRM. F. prausnitzii phylotypes differed in obese with and without developed diabetes type two. Different phylotypes of F. prausnitzii may lead to differences in the inflammatory genesis in the host. F. prausnitzii phylotypes may have an influence on developing type two diabetes and might also act as starting points for prevention and therapy of obesity associated disease.

Entities:  

Keywords:  butyryl-CoA:acetate CoA-transferase (BUT) gene; fragment length polymorphism; high resolution melt curve analysis; low grade inflammation

Mesh:

Substances:

Year:  2016        PMID: 27048834     DOI: 10.3920/BM2015.0075

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  25 in total

Review 1.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Authors:  Mireia Lopez-Siles; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  ISME J       Date:  2017-01-03       Impact factor: 10.302

Review 2.  Manipulation of intestinal microbiome as potential treatment for insulin resistance and type 2 diabetes.

Authors:  Yasaman Ghorbani; Katherine J P Schwenger; Johane P Allard
Journal:  Eur J Nutr       Date:  2021-03-02       Impact factor: 5.614

3.  Gut Microbiota and Cardiometabolic Risk Factors in Hemodialysis Patients: A Pilot Study.

Authors:  Annabel Biruete; Jacob M Allen; Brandon M Kistler; Jin Hee Jeong; Peter J Fitschen; Kelly S Swanson; Kenneth R Wilund
Journal:  Top Clin Nutr       Date:  2019 Apr-Jun       Impact factor: 0.508

4.  Mogroside-Rich Extract From Siraitia grosvenorii Fruits Ameliorates High-Fat Diet-Induced Obesity Associated With the Modulation of Gut Microbiota in Mice.

Authors:  Siyuan Wang; Kexin Cui; Jiahao Liu; Jiahao Hu; Ke Yan; Peng Xiao; Yangqing Lu; Xiaogan Yang; Xingwei Liang
Journal:  Front Nutr       Date:  2022-06-13

5.  Taxonomic and Functional Fecal Microbiota Signatures Associated With Insulin Resistance in Non-Diabetic Subjects With Overweight/Obesity Within the Frame of the PREDIMED-Plus Study.

Authors:  Alessandro Atzeni; Thomaz F S Bastiaanssen; John F Cryan; Francisco J Tinahones; Jesús Vioque; Dolores Corella; Montserrat Fitó; Josep Vidal; Isabel Moreno-Indias; Ana M Gómez-Pérez; Laura Torres-Collado; Oscar Coltell; Olga Castañer; Monica Bulló; Jordi Salas-Salvadó
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

6.  Enterotype May Drive the Dietary-Associated Cardiometabolic Risk Factors.

Authors:  Ana C F de Moraes; Gabriel R Fernandes; Isis T da Silva; Bianca Almeida-Pititto; Everton P Gomes; Alexandre da Costa Pereira; Sandra R G Ferreira
Journal:  Front Cell Infect Microbiol       Date:  2017-02-23       Impact factor: 5.293

Review 7.  A review on gut microbiota: a central factor in the pathophysiology of obesity.

Authors:  A L Cunningham; J W Stephens; D A Harris
Journal:  Lipids Health Dis       Date:  2021-07-07       Impact factor: 3.876

Review 8.  Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome.

Authors:  Siegfried Ussar; Shiho Fujisaka; C Ronald Kahn
Journal:  Mol Metab       Date:  2016-07-18       Impact factor: 7.422

9.  Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.

Authors:  Alessandra Riva; Francesca Borgo; Carlotta Lassandro; Elvira Verduci; Giulia Morace; Elisa Borghi; David Berry
Journal:  Environ Microbiol       Date:  2016-08-22       Impact factor: 5.491

10.  New Insights into the Diversity of the Genus Faecalibacterium.

Authors:  Leandro Benevides; Sriti Burman; Rebeca Martin; Véronique Robert; Muriel Thomas; Sylvie Miquel; Florian Chain; Harry Sokol; Luis G Bermudez-Humaran; Mark Morrison; Philippe Langella; Vasco A Azevedo; Jean-Marc Chatel; Siomar Soares
Journal:  Front Microbiol       Date:  2017-09-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.